chatterbait|基石药业-B获非执行董事Kenneth Walton Hitchner III增持221.95万股股份

Business 2024年05月02日 15:20 4 editor

Keystone Pharmaceuticals-B (02616) announcedchatterbaitMr. Kenneth Walton Hitchner III, non-executive director of the company, purchased a total of 221 on the open market with his own funds between April 9 and April 19, 2024chatterbait.950,000 shares, with an average buying price of approximately HKD 0.86. After making the share purchase, Mr. Hitchner held a total of approximately 2.6135 million shares, representing approximately 0.20% of the company's total issued share capital as at the date of this announcement.

Mr. Hitchner expressed to the company that he was full of confidence in the company's future prospects, and that increasing his shareholding in the company represented his belief in the company's ability to maintain stable operations while achieving rapid growth in a complex and ever-changing market environment, as well as the company's growth and development. Unremittingly support. Mr. Hitchner does not rule out the possibility of increasing his stake in the company at an appropriate time.